v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Cash Flows from Operating Activities        
Net loss $ (131,768,424) $ (91,628,613) $ (304,447,183) $ (326,984,240)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation     67,016,811 29,174,038
Revaluation of warrants and derivative liabilities 4,829,873 (2,301,086) (58,787,404) 805,137
Loss on exchange of warrants 0 0 57,770,454 0
Other financing costs - initial recognition of warrants     70,366,183 17,914,480
Amortization of debt discount and other non-cash interest expense     47,440,071 8,366,613
Depreciation and amortization     12,551,141 17,768,083
(Gain)/loss on extinguishment of debt (250,000) 690,346 (1,803,771) 655,721
Write-down of inventory to net realizable value 8,900,000 0 9,724,757 0
Gain on settlement (3,761,955) 0 (3,761,955) 0
Loss on settlement (GEM case) 14,261,736 (0) 14,261,736 (0)
Impairment of intangible assets 326,173 0 12,332,625 73,447,067
Impairment of goodwill 0 0 0 28,846,832
Impairment of right-of -use assets 0 30,060 0 3,197,668
Other financing costs - ELOC commitment fee (0) 6,000,000 (0) 6,000,000
Deferred income taxes     0 (3,890,100)
Loss/(gain) on assets disposal     0 477,838
Changes in operating assets and liabilities:        
Accounts receivable     124,295 671,750
Inventories     (685,798) (21,027,871)
Prepaids and other assets     5,362,872 (279,024)
Accounts payable     3,383,278 18,788,174
Accrued expenses and other liabilities     1,755,790 1,757,670
Right-of-use assets and lease liabilities     (2,011,664) (872,733)
Net cash used in operating activities     (69,407,762) (145,182,897)
Cash Flows from Investing Activities        
Purchase of equipment     (4,239,551) (14,053,838)
Net cash used in investing activities     (4,239,551) (14,053,838)
Cash Flows from Financing Activities        
Proceeds from issuance of convertible notes payable with detachable warrants     62,483,225 12,450,000
Issuance of stock under equity line of credit     1,017,135 0
Net cash provided by financing activities     63,750,360 7,504,168
Change in cash     (9,896,953) (151,732,567)
Cash and restricted cash (in amount of $426,851), beginning of period     10,748,678 155,696,470
Cash and restricted cash (in amount of $397,067), ending of period $ 851,725 $ 3,963,903 851,725 3,963,903
Supplemental disclosure of Cash Flow information:        
Cash paid for interest     625,000 37,458
Supplemental Disclosure for Non-Cash Activities:        
Exercise of warrants recognized earlier as liabilities     112,386,589 67,826,884
Settlement of a liability by noncurrent assets (GEM case)     45,989,264 0
Change in noncontrolling interest upon additional investments into subsidiary     1,598,668 0
Right-of-use assets obtained in exchange of operating lease liabilities     0 11,867,625
Extinguishment of accounts payable with recognition of derivatives     0 4,623,655
Common stock issued to settle other derivative liability     0 3,293,965
Common stock issued to extinguish other liabilities     0 639,146
Conversion of Notes and Interest to Common Stock [Member]        
Supplemental Disclosure for Non-Cash Activities:        
Convertible notes and interest - conversion to common stock     27,579,425 8,136,004
Conversion of Debt and Interest into Common Stock [Member]        
Supplemental Disclosure for Non-Cash Activities:        
Extinguishment of debt and interest (in exchange for own common stock)     4,553,771 0
Subsidiaries [Member]        
Cash Flows from Financing Activities        
Proceeds from issuance of notes payable     11,250,000 0
Payment of notes payable     (11,000,000) 0
Consolidated Entity, Excluding Subsidiaries [Member]        
Cash Flows from Financing Activities        
Payment of notes payable     $ 0 $ (4,945,832)